Innovita Biological Technology Co., Ltd. (SHA:688253)
34.80
+1.16 (3.45%)
Mar 6, 2026, 4:00 PM EST
SHA:688253 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 4,684 | 4,070 | 4,948 | 3,403 | 3,241 | - | Upgrade
|
| Market Cap Growth | 14.23% | -17.74% | 45.41% | 5.00% | - | - | Upgrade
|
| Enterprise Value | 2,840 | 2,227 | 3,088 | 1,921 | 1,811 | - | Upgrade
|
| Last Close Price | 34.73 | 30.18 | 35.60 | 24.31 | 22.99 | - | Upgrade
|
| PE Ratio | 32.46 | 27.87 | 20.04 | 19.56 | 21.51 | - | Upgrade
|
| PS Ratio | 11.10 | 9.65 | 7.96 | 7.12 | 7.26 | - | Upgrade
|
| PB Ratio | 2.30 | 2.00 | 2.48 | 1.85 | 1.92 | - | Upgrade
|
| P/TBV Ratio | 2.32 | 2.01 | 2.49 | 1.85 | 1.93 | - | Upgrade
|
| P/FCF Ratio | - | - | 18.37 | 14.01 | 47.17 | - | Upgrade
|
| P/OCF Ratio | - | - | 16.20 | 13.10 | 25.64 | - | Upgrade
|
| EV/Sales Ratio | 6.73 | 5.28 | 4.97 | 4.02 | 4.06 | - | Upgrade
|
| EV/EBITDA Ratio | 15.85 | 12.42 | 11.94 | 9.56 | 16.30 | - | Upgrade
|
| EV/EBIT Ratio | 17.69 | 13.87 | 12.87 | 10.73 | 19.15 | - | Upgrade
|
| EV/FCF Ratio | - | - | 11.47 | 7.91 | 26.36 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.03 | 0.02 | 0.01 | 0.20 | 0.01 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.02 | 0.01 | 0.34 | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.91 | -0.91 | -0.95 | -0.92 | -0.88 | -0.77 | Upgrade
|
| Net Debt / EBITDA Ratio | -10.29 | -10.29 | -7.29 | -8.43 | -13.32 | -3.89 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -7.00 | -6.97 | -21.54 | -13.30 | Upgrade
|
| Asset Turnover | - | - | 0.29 | 0.24 | 0.33 | 0.41 | Upgrade
|
| Inventory Turnover | - | - | 2.43 | 2.06 | 2.94 | 1.88 | Upgrade
|
| Quick Ratio | - | - | 9.19 | 8.38 | 6.74 | 10.96 | Upgrade
|
| Current Ratio | - | - | 9.50 | 8.70 | 7.15 | 12.42 | Upgrade
|
| Return on Equity (ROE) | 7.26% | 7.26% | 12.87% | 9.85% | 12.41% | 17.09% | Upgrade
|
| Return on Assets (ROA) | - | - | 7.01% | 5.58% | 4.32% | 10.46% | Upgrade
|
| Return on Invested Capital (ROIC) | 77.45% | 98.78% | 168.04% | 87.88% | 45.40% | 91.02% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 12.00% | 9.70% | 5.60% | 17.70% | Upgrade
|
| Earnings Yield | 3.12% | 3.59% | 4.99% | 5.11% | 4.65% | - | Upgrade
|
| FCF Yield | - | - | 5.44% | 7.14% | 2.12% | - | Upgrade
|
| Dividend Yield | 1.61% | - | 1.57% | 1.65% | 0.72% | - | Upgrade
|
| Payout Ratio | - | - | 22.05% | 13.02% | 0.14% | 41.63% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.08% | -0.36% | -11.83% | -19.24% | -2.90% | Upgrade
|
| Total Shareholder Return | 1.53% | -0.08% | 1.21% | -10.19% | -18.52% | -2.90% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.